To assess whether LATS1-mediated autophagy repression exerts a general function in various types of cancer therapy, we analyzed vemurafenib-mediated BRAF inhibition (BRAFi) in BRAFV600E-mutant A2058 melanoma cells. Here, LATS1 is linked to cancer.